171 related articles for article (PubMed ID: 26079301)
1. Ethnicity, deprivation and screening: survival from breast cancer among screening-eligible women in the West Midlands diagnosed from 1989 to 2011.
Morris M; Woods LM; Rogers N; O'Sullivan E; Kearins O; Rachet B
Br J Cancer; 2015 Jul; 113(3):548-55. PubMed ID: 26079301
[TBL] [Abstract][Full Text] [Related]
2. Socio-economic inequalities in survival from screen-detected breast cancer in South West England: population-based cohort study.
McKenzie F; Ives A; Jeffreys M
Eur J Public Health; 2012 Jun; 22(3):418-22. PubMed ID: 21891789
[TBL] [Abstract][Full Text] [Related]
3. Impact of deprivation on breast cancer survival among women eligible for mammographic screening in the West Midlands (UK) and New South Wales (Australia): Women diagnosed 1997-2006.
Woods LM; Rachet B; O'Connell D; Lawrence G; Coleman MP
Int J Cancer; 2016 May; 138(10):2396-403. PubMed ID: 26756181
[TBL] [Abstract][Full Text] [Related]
4. Socioeconomic and ethnic inequalities in screen-detected breast cancer in London.
Davies EA; Renshaw C; Dixon S; Møller H; Coupland VH
J Public Health (Oxf); 2013 Dec; 35(4):607-15. PubMed ID: 23440707
[TBL] [Abstract][Full Text] [Related]
5. Do pre-diagnosis primary care consultation patterns explain deprivation-specific differences in net survival among women with breast cancer? An examination of individually-linked data from the UK West Midlands cancer registry, national screening programme and Clinical Practice Research Datalink.
Morris M; Woods LM; Bhaskaran K; Rachet B
BMC Cancer; 2017 Feb; 17(1):155. PubMed ID: 28231774
[TBL] [Abstract][Full Text] [Related]
6. Are international differences in breast cancer survival between Australia and the UK present amongst both screen-detected women and non-screen-detected women? survival estimates for women diagnosed in West Midlands and New South Wales 1997-2006.
Woods LM; Rachet B; O'Connell DL; Lawrence G; Coleman MP
Int J Cancer; 2016 May; 138(10):2404-14. PubMed ID: 26756306
[TBL] [Abstract][Full Text] [Related]
7. Impact of mammographic screening on ethnic and socioeconomic inequities in breast cancer stage at diagnosis and survival in New Zealand: a cohort study.
Seneviratne S; Campbell I; Scott N; Shirley R; Lawrenson R
BMC Public Health; 2015 Jan; 15():46. PubMed ID: 25637343
[TBL] [Abstract][Full Text] [Related]
8. What might explain deprivation-specific differences in the excess hazard of breast cancer death amongst screen-detected women? Analysis of patients diagnosed in the West Midlands region of England from 1989 to 2011.
Morris M; Woods LM; Rachet B
Oncotarget; 2016 Aug; 7(31):49939-49947. PubMed ID: 27363022
[TBL] [Abstract][Full Text] [Related]
9. Comparative Access to and Use of Digital Breast Tomosynthesis Screening by Women's Race/Ethnicity and Socioeconomic Status.
Lee CI; Zhu W; Onega T; Henderson LM; Kerlikowske K; Sprague BL; Rauscher GH; O'Meara ES; Tosteson ANA; Haas JS; diFlorio-Alexander R; Kaplan C; Miglioretti DL
JAMA Netw Open; 2021 Feb; 4(2):e2037546. PubMed ID: 33606032
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer screening uptake among women from different ethnic groups in London: a population-based cohort study.
Jack RH; Møller H; Robson T; Davies EA
BMJ Open; 2014 Oct; 4(10):e005586. PubMed ID: 25324320
[TBL] [Abstract][Full Text] [Related]
11. No 'cure' within 12 years of diagnosis among breast cancer patients who are diagnosed via mammographic screening: women diagnosed in the West Midlands region of England 1989-2011.
Woods LM; Morris M; Rachet B
Ann Oncol; 2016 Nov; 27(11):2025-2031. PubMed ID: 27573567
[TBL] [Abstract][Full Text] [Related]
12. European transnational ecological deprivation index and participation in population-based breast cancer screening programmes in France.
Ouédraogo S; Dabakuyo-Yonli TS; Roussot A; Pornet C; Sarlin N; Lunaud P; Desmidt P; Quantin C; Chauvin F; Dancourt V; Arveux P
Prev Med; 2014 Jun; 63():103-8. PubMed ID: 24345603
[TBL] [Abstract][Full Text] [Related]
13. Racial/Ethnic Differences Affecting Adherence to Cancer Screening Guidelines Among Women.
Hirth JM; Laz TH; Rahman M; Berenson AB
J Womens Health (Larchmt); 2016 Apr; 25(4):371-80. PubMed ID: 26579735
[TBL] [Abstract][Full Text] [Related]
14. Deprivation and mass screening: Survival of women diagnosed with breast cancer in France from 2008 to 2010.
Poiseuil M; Coureau G; Payet C; Savès M; Debled M; Mathoulin-Pelissier S; Amadeo B
Cancer Epidemiol; 2019 Jun; 60():149-155. PubMed ID: 31015096
[TBL] [Abstract][Full Text] [Related]
15. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
16. Barriers to mammography screening among racial and ethnic minority women.
Miller BC; Bowers JM; Payne JB; Moyer A
Soc Sci Med; 2019 Oct; 239():112494. PubMed ID: 31513931
[TBL] [Abstract][Full Text] [Related]
17. Screening Mammography in a Public Hospital Serving Predominantly African-American Women: A Stage-Survival-Cost Model.
Farley C; Friedman D; Habtes I; Raskind-Hood C; Adams EK; Becker ER; D'Orsi C; Gundry K; Birdsong G; Gabram-Mendola S
Womens Health Issues; 2015; 25(4):322-30. PubMed ID: 25910513
[TBL] [Abstract][Full Text] [Related]
18. Comparison of prognostic and socio-economic factors in screen-detected and symptomatic cases of breast cancer.
Garvican L; Littlejohns P
Public Health; 1998 Jan; 112(1):15-20. PubMed ID: 9490883
[TBL] [Abstract][Full Text] [Related]
19. Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.
Lawrence G; Wallis M; Allgood P; Nagtegaal ID; Warwick J; Cafferty FH; Houssami N; Kearins O; Tappenden N; O'Sullivan E; Duffy SW
Breast Cancer Res Treat; 2009 Jul; 116(1):179-85. PubMed ID: 18622697
[TBL] [Abstract][Full Text] [Related]
20. Disparities in mortality-to-incidence ratios by race/ethnicity for female breast cancer in New York City, 2002-2016.
Nobel TB; Asumeng CK; Jasek J; Van Beck KC; Mathur R; Qiao B; Brown JJ
Cancer Med; 2020 Nov; 9(21):8226-8234. PubMed ID: 33006431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
